SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-06-201457
Filing Date
2006-10-03
Accepted
2006-10-03 06:21:17
Documents
1
Group Members
ATLAS GLOBAL INVESTMENTS II, LTDATLAS GLOBAL INVESTMENTS, LTDATLAS GLOBAL, LLCATLAS MASTER FUND, LTDDMITRY BALYASNYVISIUM BALANCED FUND, LPVISIUM BALANCED LONG BIAS FUND, LTDVISIUM BALANCED OFFSHORE FUND, LTDVISIUM CAPITAL MANAGEMENT, LLCVISIUM LONG BIAS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 305520
  Complete submission text file 0001193125-06-201457.txt   307656
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-81801 | Film No.: 061122342
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 181 W MADISON STE 3600 CHICAGO IL 60602
Business Address 181 W MADISON STE 3600 CHICAGO IL 60602 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G